Melody Noel Brown

Array ( [id] => 9422529 [patent_doc_number] => 20140107180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-17 [patent_title] => 'MODULATION OF ANDROGEN RECEPTOR EXPRESSION' [patent_app_type] => utility [patent_app_number] => 14/050574 [patent_app_country] => US [patent_app_date] => 2013-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65411 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14050574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9409010 [patent_doc_number] => 20140100262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-10 [patent_title] => 'Methods and Compositions for Maintaining Blood-Brain Barrier Integrity' [patent_app_type] => utility [patent_app_number] => 14/047585 [patent_app_country] => US [patent_app_date] => 2013-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18073 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14047585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9657417 [patent_doc_number] => 20140228422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'TARGETS FOR TREATMENT OF ER STRESS' [patent_app_type] => utility [patent_app_number] => 14/029890 [patent_app_country] => US [patent_app_date] => 2013-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12424 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14029890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10162786 [patent_doc_number] => 09194005 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-24 [patent_title] => 'Methods and biomarker for evaluating cancer metastasis, pharmaceutical composition for inhibiting cancer metastasis, and method for analyzing secretome' [patent_app_type] => utility [patent_app_number] => 14/028861 [patent_app_country] => US [patent_app_date] => 2013-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 3562 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14028861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10318842 [patent_doc_number] => 20150203845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-23 [patent_title] => 'DOUBLE-STRANDED OLIGONUCLEOTIDE MOLECULES TO P53 AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/421845 [patent_app_country] => US [patent_app_date] => 2013-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51912 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14421845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10318842 [patent_doc_number] => 20150203845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-23 [patent_title] => 'DOUBLE-STRANDED OLIGONUCLEOTIDE MOLECULES TO P53 AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/421845 [patent_app_country] => US [patent_app_date] => 2013-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51912 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14421845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10019880 [patent_doc_number] => 09062351 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-23 [patent_title] => 'Diagnostic, prognostic and therapeutic uses of long non-coding RNAs for cancer and regenerative medicine' [patent_app_type] => utility [patent_app_number] => 14/020811 [patent_app_country] => US [patent_app_date] => 2013-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 44 [patent_no_of_words] => 45867 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14020811 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9339813 [patent_doc_number] => 20140066595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'Modulators of Protein Production in a Human Cell Line and Cell-free Extracts Produced Therefrom' [patent_app_type] => utility [patent_app_number] => 14/010246 [patent_app_country] => US [patent_app_date] => 2013-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9445 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14010246 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9537121 [patent_doc_number] => 20140161769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-12 [patent_title] => 'METHODS FOR TREATING INFLAMMATORY AUTOIMMUNE DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/936792 [patent_app_country] => US [patent_app_date] => 2013-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 14447 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13936792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10579879 [patent_doc_number] => 09301990 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-05 [patent_title] => 'Small molecule conjugates for intracellular delivery of biologically active compounds' [patent_app_type] => utility [patent_app_number] => 13/917524 [patent_app_country] => US [patent_app_date] => 2013-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 28605 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13917524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9192121 [patent_doc_number] => 20130331436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'MICRORNAS AS NEW THERAPEUTIC TARGETS FOR THE PREVENTION AND/OR TREATMENT OF RETINOPATHY' [patent_app_type] => utility [patent_app_number] => 13/907399 [patent_app_country] => US [patent_app_date] => 2013-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 29613 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13907399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14454659 [patent_doc_number] => 10323282 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-18 [patent_title] => Methods and compositions for assessing patients with preeclampsia-related conditions using microrna [patent_app_type] => utility [patent_app_number] => 13/899555 [patent_app_country] => US [patent_app_date] => 2013-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 12069 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13899555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14454659 [patent_doc_number] => 10323282 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-18 [patent_title] => Methods and compositions for assessing patients with preeclampsia-related conditions using microrna [patent_app_type] => utility [patent_app_number] => 13/899555 [patent_app_country] => US [patent_app_date] => 2013-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 12069 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13899555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9882551 [patent_doc_number] => 08969317 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-03 [patent_title] => 'MicroRNA compounds and methods for modulating miR-21 activity' [patent_app_type] => utility [patent_app_number] => 13/869177 [patent_app_country] => US [patent_app_date] => 2013-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 43967 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13869177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9107631 [patent_doc_number] => 20130280763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-24 [patent_title] => 'ARCHEASE AS RNA LIGASE COMPLEX MEMBER' [patent_app_type] => utility [patent_app_number] => 13/868750 [patent_app_country] => US [patent_app_date] => 2013-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13043 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13868750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9909036 [patent_doc_number] => 20150064237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-05 [patent_title] => 'MEDICINAL COMPOSITION FOR TREATING INFARCTION' [patent_app_type] => utility [patent_app_number] => 14/391302 [patent_app_country] => US [patent_app_date] => 2013-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5121 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14391302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9095003 [patent_doc_number] => 20130274314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'MITOCHONDRIAL TARGETED RNA EXPRESSION SYSTEM AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/860156 [patent_app_country] => US [patent_app_date] => 2013-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10612 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13860156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9817731 [patent_doc_number] => 08927517 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-06 [patent_title] => 'Factors controlling skin and hair color' [patent_app_type] => utility [patent_app_number] => 13/858374 [patent_app_country] => US [patent_app_date] => 2013-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13099 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13858374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10014057 [patent_doc_number] => 09057068 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-06-16 [patent_title] => 'Methods and compositions using miR-3151 in the diagnosis and treatment of cancer' [patent_app_type] => utility [patent_app_number] => 13/854643 [patent_app_country] => US [patent_app_date] => 2013-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 80 [patent_no_of_words] => 29637 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13854643 [rel_patent_id] =>[rel_patent_doc_number] =>)